Parsabiv 2.5 mg
Parsabiv 2.5 mg is a medicine authorised by Swissmedic under authorisation number 66338. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 September 2017 and the authorisation is valid without a time limit. ATC code H05BX04 places the medicine in the group Calcium homeostasis.
| Authorisation number | 66338 |
|---|---|
| Name | Parsabiv 2.5 mg |
| Full name | Parsabiv 2.5 mg, Injektionslösung |
| Authorisation holder | Amgen Switzerland AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | H05BX04 |
| First authorisation | 27 September 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Parsabiv 2.5 mg, Injektionslösung | B | 27 September 2017 |
| 2 | Parsabiv 5.0 mg, Injektionslösung | B | 27 September 2017 |
| 3 | Parsabiv 10.0 mg, Injektionslösung | B | 27 September 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 6 | Durchstechflasche(n) | H05BX04 | 07.05.0. | B |
| 2 | 6 | Durchstechflasche(n) | H05BX04 | 07.05.0. | B |
| 3 | 6 | Durchstechflasche(n) | H05BX04 | 07.05.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Parsabiv 2.5 mg authorised in Switzerland?
Yes. Parsabiv 2.5 mg is authorised by Swissmedic under authorisation number 66338, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Parsabiv 2.5 mg have?
Parsabiv 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Parsabiv 2.5 mg?
The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.